ATE156017T1 - Wachstumsfaktor und glutamin enthaltendes produkt und verwendung des wachstumsfaktors zur behandlung der darmschleimhaut - Google Patents
Wachstumsfaktor und glutamin enthaltendes produkt und verwendung des wachstumsfaktors zur behandlung der darmschleimhautInfo
- Publication number
- ATE156017T1 ATE156017T1 AT91915528T AT91915528T ATE156017T1 AT E156017 T1 ATE156017 T1 AT E156017T1 AT 91915528 T AT91915528 T AT 91915528T AT 91915528 T AT91915528 T AT 91915528T AT E156017 T1 ATE156017 T1 AT E156017T1
- Authority
- AT
- Austria
- Prior art keywords
- growth factor
- glutamine
- treatment
- containing product
- intestinal mucosa
- Prior art date
Links
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 title abstract 4
- 239000003102 growth factor Substances 0.000 title 2
- 210000004347 intestinal mucosa Anatomy 0.000 title 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 abstract 2
- 206010003694 Atrophy Diseases 0.000 abstract 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 abstract 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 abstract 1
- 150000008575 L-amino acids Chemical class 0.000 abstract 1
- KSMRODHGGIIXDV-YFKPBYRVSA-N N-acetyl-L-glutamine Chemical compound CC(=O)N[C@H](C(O)=O)CCC(N)=O KSMRODHGGIIXDV-YFKPBYRVSA-N 0.000 abstract 1
- 230000037444 atrophy Effects 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 210000005205 gut mucosa Anatomy 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9002732A SE9002732D0 (sv) | 1990-08-24 | 1990-08-24 | Product containing growth factor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE156017T1 true ATE156017T1 (de) | 1997-08-15 |
Family
ID=20380209
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91915528T ATE156017T1 (de) | 1990-08-24 | 1991-08-22 | Wachstumsfaktor und glutamin enthaltendes produkt und verwendung des wachstumsfaktors zur behandlung der darmschleimhaut |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US5462924A (de) |
| EP (1) | EP0547099B1 (de) |
| JP (1) | JPH06500109A (de) |
| AT (1) | ATE156017T1 (de) |
| AU (1) | AU648820B2 (de) |
| CA (1) | CA2089257A1 (de) |
| DE (1) | DE69127087T2 (de) |
| DK (1) | DK0547099T3 (de) |
| ES (1) | ES2107470T3 (de) |
| GR (1) | GR3025047T3 (de) |
| SE (1) | SE9002732D0 (de) |
| WO (1) | WO1992003155A1 (de) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE165008T1 (de) * | 1990-02-13 | 1998-05-15 | Gropep Pty Ltd | Methode zur behandlung intestinaler krankheiten |
| US5679771A (en) * | 1990-02-13 | 1997-10-21 | Gropep Pty. Ltd. | Method for treating intestinal diseases |
| CA2120626C (en) * | 1991-10-07 | 2009-10-06 | Douglas Wilmore | Method for enhancing gut absorption |
| NZ260309A (en) * | 1992-06-08 | 1997-07-27 | Pharmacia Ab Substituted For K | Use of 1gf-2 for prevention or treatment of nutritional or gastrointestinal disorders and promoting neonatal growth |
| WO1993025226A1 (en) * | 1992-06-08 | 1993-12-23 | Kabi Pharmacia Ab | Use of growth factor igf-i and/or igf-ii |
| DK25493D0 (da) * | 1993-03-09 | 1993-03-09 | Novo Nordisk As | A method of treating a mammal with a biologically active compound |
| RO115498B1 (ro) * | 1993-10-29 | 2000-03-30 | Univ Boston | Metoda de tratament a neoplasmului |
| GB9512100D0 (en) * | 1995-06-14 | 1995-08-09 | Sandoz Nutrition Ltd | Improvements in or relating to organic compounds |
| US5814308A (en) * | 1996-03-26 | 1998-09-29 | Zhang; Ke | Methods for the treatment of gastrointestinal tract disorders |
| EP0875155A1 (de) * | 1997-05-01 | 1998-11-04 | N.V. Nutricia | Perioperatives Getränk |
| AU774861B2 (en) | 1998-02-11 | 2004-07-08 | Douglas V Faller | Compositions and methods for the treatment of cystic fibrosis |
| WO2001024812A1 (en) * | 1999-10-06 | 2001-04-12 | N.V. Nutricia | USE OF TRANSFORMING GROWTH FACTOR β AND GROWTH FACTORS IN THE TREATMENT AND PREVENTION OF DISEASES OF THE INTESTINAL MUCOSA |
| DE10057290B4 (de) | 2000-11-17 | 2004-01-08 | Fresenius Kabi Deutschland Gmbh | Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten |
| EP1262188A1 (de) * | 2001-05-22 | 2002-12-04 | Centre National De La Recherche Scientifique (Cnrs) | Verbesserter neuronaler Gentransfer |
| US20030099722A1 (en) * | 2001-10-09 | 2003-05-29 | Baxter Jeffrey H. | Methods and compositions for providing glutamine |
| WO2004032653A1 (en) * | 2002-10-08 | 2004-04-22 | Abbott Laboratories | Methods and compositions for providing glutamine |
| SE526711C2 (sv) * | 2003-01-31 | 2005-10-25 | Probi Ab | Nya stammar av Bifidobacterium med förmåga att överleva i magtarmkanalen och producera glutamin in vivo, samt kompositioner och användningar därav |
| WO2007014167A2 (en) * | 2005-07-22 | 2007-02-01 | Five Prime Therapeutics, Inc. | Compositions for and methods of treating epithelial diseases with growth factors |
| WO2009154463A2 (en) * | 2008-06-20 | 2009-12-23 | Stichting Top Institute Food And Nutrition | Butyrate as a medicament to improve visceral perception in humans |
| US20110086869A1 (en) | 2009-09-24 | 2011-04-14 | The Trustees Of Boston University | Methods for treating viral disorders |
| EP2509418A4 (de) | 2009-12-08 | 2013-03-20 | Hemaquest Pharmaceuticals Inc | Verfahren und niedrigdosierungspläne zur behandlung von erythrozytendysfunktion |
| US20110245154A1 (en) | 2010-03-11 | 2011-10-06 | Hemaquest Pharmaceuticals, Inc. | Methods and Compositions for Treating Viral or Virally-Induced Conditions |
| KR20220034736A (ko) | 2019-05-31 | 2022-03-18 | 비락타 서브시디어리 인크. | 히스톤 데아세틸라제 억제제를 사용하여 바이러스 관련 암을 치료하는 방법 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0177342A3 (de) * | 1984-10-04 | 1987-12-02 | Genentech, Inc. | Orale Formulierungen therapeutischer Proteine |
| CA1285491C (en) * | 1985-09-12 | 1991-07-02 | Robert J. Smith | Method of treating catabolic dysfunction |
| WO1987003806A1 (en) * | 1985-12-18 | 1987-07-02 | Veech Richard L | Parenteral nutrition therapy with amino acids |
| CA1320441C (en) * | 1986-01-09 | 1993-07-20 | Douglas W. Wilmore | Use of growth hormone for nitrogen retention under hypocaloric conditions |
| DE3852636T2 (de) * | 1987-12-24 | 1995-05-04 | Gropep Pty Ltd | Peptid-analoge vom insulinähnlichen wachstums-faktor 1 (igf-1) oder faktor 2 (igf-2). |
| US5258287A (en) * | 1988-03-22 | 1993-11-02 | Genentech, Inc. | DNA encoding and methods of production of insulin-like growth factor binding protein BP53 |
| IL94549A (en) * | 1989-06-02 | 1996-08-04 | Brigham & Womens Hospital | A pharmaceutical preparation containing glutamine |
| DK657689D0 (da) * | 1989-12-22 | 1989-12-22 | Novo Nordisk As | Middel med biologisk virkning paa tarmslimhinden |
| ATE165008T1 (de) * | 1990-02-13 | 1998-05-15 | Gropep Pty Ltd | Methode zur behandlung intestinaler krankheiten |
-
1990
- 1990-08-24 SE SE9002732A patent/SE9002732D0/xx unknown
-
1991
- 1991-08-22 US US07/975,558 patent/US5462924A/en not_active Expired - Fee Related
- 1991-08-22 DK DK91915528.3T patent/DK0547099T3/da active
- 1991-08-22 ES ES91915528T patent/ES2107470T3/es not_active Expired - Lifetime
- 1991-08-22 EP EP91915528A patent/EP0547099B1/de not_active Revoked
- 1991-08-22 DE DE69127087T patent/DE69127087T2/de not_active Revoked
- 1991-08-22 CA CA002089257A patent/CA2089257A1/en not_active Abandoned
- 1991-08-22 WO PCT/SE1991/000558 patent/WO1992003155A1/en not_active Application Discontinuation
- 1991-08-22 AU AU84359/91A patent/AU648820B2/en not_active Ceased
- 1991-08-22 AT AT91915528T patent/ATE156017T1/de not_active IP Right Cessation
- 1991-08-22 JP JP3514810A patent/JPH06500109A/ja active Pending
-
1995
- 1995-05-05 US US08/435,481 patent/US5646118A/en not_active Expired - Fee Related
-
1997
- 1997-10-15 GR GR970402693T patent/GR3025047T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0547099B1 (de) | 1997-07-30 |
| AU648820B2 (en) | 1994-05-05 |
| AU8435991A (en) | 1992-03-17 |
| CA2089257A1 (en) | 1992-02-25 |
| SE9002732D0 (sv) | 1990-08-24 |
| US5462924A (en) | 1995-10-31 |
| JPH06500109A (ja) | 1994-01-06 |
| DE69127087D1 (de) | 1997-09-04 |
| EP0547099A1 (de) | 1993-06-23 |
| WO1992003155A1 (en) | 1992-03-05 |
| GR3025047T3 (en) | 1998-01-30 |
| ES2107470T3 (es) | 1997-12-01 |
| DE69127087T2 (de) | 1998-01-15 |
| DK0547099T3 (da) | 1998-03-09 |
| US5646118A (en) | 1997-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE156017T1 (de) | Wachstumsfaktor und glutamin enthaltendes produkt und verwendung des wachstumsfaktors zur behandlung der darmschleimhaut | |
| DE68919358D1 (de) | Zusammensetzung zur behandlung der schizophrenie. | |
| DE69625691D1 (de) | Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten | |
| NO990279L (no) | Isobutylgaba og dets derivater for behandling av smerte | |
| DE3684190D1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
| ATE73657T1 (de) | Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose. | |
| MY132626A (en) | CARBAZOLYL-SUBSTITUTED ETHANOLAMINES AS SELECTIVE ß-3 AGONISTS | |
| ATE222489T1 (de) | Thyroxin-analoga ohne bedeutende hormonale wirkung zur behandlung von bösartigen tumoren | |
| DE69827651D1 (de) | Verwendung von tempol zur behandlung von essentiellem hochdruck | |
| ATE257378T1 (de) | Phenylacetylglutamin, phenylacetylisoglutamin, und/oder phenylacetat zur behandlung von neoplastischen erkrankungen | |
| HU895785D0 (en) | Process for the preparation of compositions and medical preparations containing acid-resistent fibroplast growth activator for treating gastrointestinal ulcer | |
| ATE77751T1 (de) | Mittel zur behandlung von knochenkrankheiten. | |
| ATE260107T1 (de) | Debromhymenialdisin und verwandte verbindungen zur behandlung von osteoarthritis | |
| ATE220923T1 (de) | Rekombinante adenoviren und deren verwendung in der gentherapie zur behandlung von augenerkrankungen | |
| UA27102C2 (uk) | Склад для стабілізації плазми крові у процесі пастеризації, спосіб пастеризації плазми крові і засіб для терапії препаратом плазми | |
| ATE165008T1 (de) | Methode zur behandlung intestinaler krankheiten | |
| DE69328193D1 (de) | Verwendung von prodelphidinen zur behandlung von arthrose | |
| DE3854121D1 (de) | Arzneimittelzusammensetzungen zur behandlung von psoriasis. | |
| DE69315085T2 (de) | 1,4-disubstituierte piperazine zur behandlung von asthma und entzündungen der atemwege | |
| DE59902666D1 (de) | Edelfosin zur behandlung von hirntumoren | |
| DE69327314D1 (de) | Zusammensetzungen enthaltend Lipoprotein-Associated-Coagulation-Inhibitor (LACI) zur Herstellung eines Medikaments zur Behandlung von akuten oder chronischen Enzündungen | |
| DK105391A (da) | Et rent faktor i produkt og fremgangsmaade til fremstilling heraf | |
| DE59608276D1 (de) | Verwendung von threonin zur behandlung der phenylketonurie | |
| DE69231465D1 (de) | Methode und zusammensetzung zur behandlung von herpes ähnlichen krankheiten | |
| DE69732851D1 (de) | Verwendung von dextrinsulfat zur behandlung von sehr vasculären tumoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee | ||
| RZN | Patent revoked |